Skip to main content

$0.580 (0%)

High

$0.59

Low

$0.57

Trades

36

Turnover

$59,341

Volume

102,948
30 June 2023 at 3:56pm
Register to track NXS and receive email alerts.
Subject
NXS Ann: Zimmer complaint

NXS Ann: Update on expected revenue for H1

NXS Ann: BlastX approved by TGA for sale in Australia

NXS Ann: Investor Presentation

NXS Ann: Appendix 3Z - G Savvides

NXS Ann: 2021 AGM - Voting Results

NXS Ann: 2021 AGM Presentation

NXS Ann: 2021 AGM Chair & Managing Director Addresses

NXS Ann: Cleansing notice

NXS Ann: Appendix 2A

NXS Ann: Appendix 3Y - D Spira

NXS Ann: Appendix 3Y - D Spira

NXS Ann: XPerience No Rinse Antimicrobial Solution cleared by FDA

NXS Ann: Appendix 2A

NXS Ann: Appendix 3Y - J Mitchell

NXS Ann: Appendix 3G

NXS Ann: Cleansing notice

NXS Ann: Appendix 3Y - D Spira

NXS Ann: Appendix 3G

NXS Ann: Appendix 2A

NXS Ann: Quarterly Activity Report - 31 March 2021

NXS Ann: Appendix 4C - 31 March 2021

NXS Ann: Notification of forthcoming release of escrowed securities

NXS Ann: Appendix 4G

NXS Ann: Next Science 2021 Corporate Governance Statement

NXS Ann: Next Science 2020 Annual Report

NXS Ann: Next Science's 2021 AGM

NXS Ann: Changes to Board of Directors

NXS Ann: Cleansing notice

NXS Ann: Appendix 2A

NXS Ann: S&P DJI Announces March 2021 Quarterly Rebalance

NXS Ann: Notification of date of 2021 AGM

NXS Ann: Full Year Results Investor Briefing Script

NXS Ann: Investor Presentation

NXS Ann: Appendix 4E / FY20 Financial Statements

NXS Ann: Appendix 3G - Performance Rights

NXS Ann: Full Year Results Investor Briefing

NXS Ann: Investor Presentation January 2021

NXS Ann: Quarterly Activity Report & Appendix 4C - 31 December 2020

NXS Ann: Next Science receives CE Mark approval for BlastX

NXS Ann: Revised Securities Trading Policy

NXS Ann: Appendix 3Y - J Mitchell

NXS Ann: Appendix 3Y - B Hancox

NXS Ann: Cleansing notice

NXS Ann: Non-renewal of 3M distribution agreement

NXS Ann: Appendix 2A

NXS Ann: General Meeting - Voting Results

NXS Ann: Managing Director's EGM Address

NXS Ann: Appendix 3Y - J Mitchell

NXS Ann: Appendix 3Y - B Hancox

Register to track NXS and receive email alerts.

Similar Companies

ANN
AVR
MGZ
NAN
OSX
PNV
SDI
SDI